...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
【24h】

Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.

机译:大鼠前列腺中α1-肾上腺素受体亚型的结合和功能表征。

获取原文
获取原文并翻译 | 示例

摘要

The alpha1-adrenoceptor subtypes of rat prostate were characterized in binding and functional experiments. In binding experiments, [3H]tamsulosin bound to a single class of binding sites with an affinity (pKD) of 10.79+/-0.04 and Bmax of 87+/-2 fmol mg(-1) protein. This binding was inhibited by prazosin, 2-(2,6-dimethoxy-phenoxyethyl)-aminomethyl-1,4-benzodioxane hydrochloride (WB4101), 5-methylurapidil, alpha-ethyl-3,4,5,-trimethoxy-alpha-(3-((2-(2-methoxyphenoxy)ethyl)-amin o)-propyl)benzeneacetonitrile fumarate (HV723) and oxymetazoline with high efficacy, resulting in a good correlation with the binding characteristics of cloned alpha1a but not alpha1b and alpha1d-adrenoceptor subtypes. In functional studies, noradrenaline and oxymetazoline produced concentration-dependent contractions. These contractions were antagonized by tamsulosin, prazosin, WB4101 and 5-methylurapidil with an efficacy lower than that exhibited by these agents for inhibition of [3H]tamsulosin binding. The relationship between receptor occupancy and contractile amplitude revealed the presence of receptor reserve for noradrenaline, but the contraction induced by oxymetazoline was not in parallel with receptor occupation and developed after predicted receptor saturation. From these results, it is suggested that alpha1A-adrenoceptors are the dominant subtype in the rat prostate which can be detected with [3H]tamsulosin, but that the functional subtype mediating adrenergic contractions has the characteristics of the alpha1L-adrenoceptor subtype, having a lower affinity for prazosin and some other drugs than the alpha1A-adrenoceptor subtype.
机译:在结合和功能实验中对大鼠前列腺的α1-肾上腺素受体亚型进行了表征。在结合实验中,[3H]坦索罗辛与单类结合位点结合,亲和力(pKD)为10.79 +/- 0.04,Bmax为87 +/- 2 fmol mg(-1)蛋白。此结合受到哌唑嗪,2-(2,6-二甲氧基-苯氧基乙基)-氨基甲基-1,4-苯并二恶烷盐酸盐(WB4101),5-甲基尿嘧啶,α-乙基-3,4,5,-三甲氧基-α-的抑制(3-(((2-(2-甲氧基苯氧基)乙基)-氨基o)-丙基)苯乙腈富马酸酯(HV723)和羟甲唑啉具有很高的功效,与克隆的alpha1a的结合特性有很好的相关性,但与alpha1b和alpha1d-没有结合肾上腺素受体亚型。在功能研究中,去甲肾上腺素和羟甲唑啉产生浓度依赖性的收缩。这些收缩被坦索罗辛,哌唑嗪,WB4101和5-甲基乌拉地尔拮抗,其功效低于这些药物对[3H]坦索罗辛结合的抑制作用。受体占有率与收缩幅度之间的关系揭示了去甲肾上腺素存在受体储备,但羟甲唑啉诱导的收缩并不与受体占据平行,而是在预测受体饱和后发展。从这些结果表明,α1A-肾上腺素受体是大鼠前列腺中的主要亚型,可以用[3H]坦索罗辛检测到,但是介导肾上腺素能收缩的功能性亚型具有α1L-肾上腺素受体亚型的特征,具有较低的对prazosin和除alpha1A-肾上腺素受体亚型以外的其他一些药物具有亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号